This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Noguchi, S. Articles by Koyama, H. Search for Related Content PubMed PubMed Citation Articles by Noguchi, S. Articles by Koyama, H.

Clonal Analysis of Human Breast Cancer by Means of the Polymerase Chain Reaction

Department of Surgery, The Center for Adult Diseases, Osaka, 3-Nakamichi 1-Chome, Higashinari-ku, Osaka 537, Japan

¹ To whom requests for reprints should be addressed, at Department of Surgery, The Center for Adult Diseases, Osaka, 3-Nakamichi 1-Chome, Higashinari-ku, Osaka 537, Japan.

Clonality of human breast cancer was analyzed in small DNA samples prepared from cryostat sections, by means of the polymerase chain reaction (PCR). The method used for clonal analysis was based on restriction fragment length polymorphism of X-chromosome-linked phosphoglycerokinase (PGK) gene and on the differential methylation of the PGK gene due to random inactivation of one of two X-chromosomes by methylation in females.

All the 20 breast cancer samples analyzed by the PCR-based method were monoclonal in origin and adjacent normal breast tissues were polyclonal. When DNA samples were prepared from widely separated sites of cancers, every sample was found to be monoclonal, always exhibiting inactivation of the same X-chromosome in each tumor. The study on sensitivity showed that the PCR-based method for clonal analysis can detect the presence of monoclonal cells against a polyclonal background when the monoclonal cell population is 50% or more. These results demonstrate that clonal analysis by means of PCR offers a good method for studying the clonality in small DNA samples prepared from cryostat sections of tumors. This method could be applied to distinguish between benign (polyclonal) and malignant (monoclonal) breast lesions.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 6/16/92. Accepted 9/24/92.

This article has been cited by other articles:

				M. Novelli, A. Cossu, D. Oukrif, A. Quaglia, S. Lakhani, R. Poulsom, P. Sasieni, P. Carta, M. Contini, A. Pasca, et al. X-inactivation patch size in human female tissue confounds the assessment of tumor clonality PNAS, March 18, 2003; 100(6): 3311 - 3314. [Abstract] [Full Text] [PDF]

				S. Niho, T. Yokose, K. Suzuki, T. Kodama, Y. Nishiwaki, and K. Mukai Monoclonality of Atypical Adenomatous Hyperplasia of the Lung Am. J. Pathol., January 1, 1999; 154(1): 249 - 254. [Abstract] [Full Text] [PDF]